On June 21, Dai Dongqiang, Secretary of the Party Group and Director of Tianjin Market Supervision and Administration Commission, visited Baishan Lincun Traditional Chinese Medicine Development Co., Ltd., a subsidiary of China Medico, for investigation and research.
▲Listen to and understand the relevant situation of China Medico
During the investigation, Director Dai Dongqiang had a detailed understanding of the company's production and processing, warehousing, ginseng base construction, ginseng planting technology and current research progress.
▲Visit the new varieties of China Medico ginseng
Dai Dongqiang and his entourage visited the company's ginseng germplasm research and breeding center on the spot, and had a detailed understanding of the yield, planting and promotion of two new ginseng varieties developed by the company, Zhongsheng Ginseng No. 1 and Shike Ginseng No. 1.
During the investigation, Director Dai Dongqiang fully affirmed the company's achievements, and pointed out that it is necessary to continuously strengthen technological innovation, give full play to its own advantages, continue to forge ahead, and make more contributions to the high-quality development of the traditional Chinese medicine industry.
The comrades in charge of the Jilin Provincial Market Supervision Department, the main responsible comrades of the Research Office and Office of the Tianjin Municipal Market Supervision Commission, the responsible comrades in charge and the relevant persons in charge of the enterprise participated in the investigation.